ly 303511 has been researched along with clodronic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cen, LP; Chiang, SW; Cui, Q; Fan, YM; Huang, Y; Lam, DS; Lin, D; Luo, JM; Pang, CP; van Rooijen, N; Zhang, XM | 1 |
1 other study(ies) available for ly 303511 and clodronic acid
Article | Year |
---|---|
PI3K/akt, JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury.
Topics: Analgesics, Non-Narcotic; Animals; Axons; Axotomy; Blotting, Western; Butadienes; Chromones; Clodronic Acid; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Immunohistochemistry; Janus Kinases; Macrophages; Morpholines; Neuroprotective Agents; Nitriles; Optic Nerve Injuries; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred F344; Retinal Ganglion Cells; Signal Transduction; STAT Transcription Factors; Tyrphostins | 2007 |